Navigation Links
Adolescent but not adult hamsters are more aggressive on low dose of fluoxetine

New research offers tantalizing clues as to why some teenagers taking common anti-depressants may become more aggressive or kill themselves. The research is published in the October Behavioral Neuroscience, which is published by the American Psychological Association (APA).

Neuroscientists at the University of Texas at Austin found that juvenile hamsters given low doses of fluoxetine hydrochloride, which is sold in the United States as Prozac, became more aggressive on low doses of the drug. Juveniles given high doses became somewhat less aggressive, but not as much as adult hamsters, who calmed down on both high and low doses.

Doctoral student and lead author Kereshmeh Taravosh-Lahn, BA, says the findings confirm that juvenile and adult brains are different. Thus, she says, "It is unwise to expect a drug to work the same in juveniles as in adults."

Fluoxetine, a selective serotonin reuptake inhibitor (SSRI), is the only medication approved to treat depression in children and adolescents. However, it has carried an FDA "black box" warning since Fall 2004 due to findings of increased risk of suicidal thoughts and behaviors in some children and adolescents on the drugs. Fluoxetine affects the regulation of serotonin, a naturally occuring neurotransmitter thought to be involved in depression, by keeping it available longer in the brain's synapses. It is known to inhibit aggression in adult hamsters. Hamsters are often used as an animal model for studying the neural basis of social behavior, given how the rodents' youthful play fighting develops in clearly understood stages into adult aggression.

In the study, researchers injected each of the experimental hamsters with high or low doses of fluoxetine. Two hours later, they put a smaller, younger same-sex hamster into the experimental hamster's home cage for 10 minutes, creating a threatening situation to which male hamsters usually respond with aggression. The neurosc ientists videotaped the encounters to document behaviors such as attacks, pins, contact time, contact bouts and target of attack.

The adult hamsters treated with either dose of fluoxetine became generally more peaceful, attacking less often and for shorter times. However, the juveniles responded differently, both to high and low doses. The low doses actually resulted in significantly longer, more frequent and intense attacks, whereas the high dose only partly inhibited aggression. Neither set of juveniles responded as well as adults; one set (low dose) actually did worse.

Thus, although fluoxetine consistently calmed the adults in a potentially threatening situation, it differentially affected the juveniles. The effects of fluoxetine on aggressive responses appear to be specific to both age and dose.

The authors say their data add to growing evidence that during puberty, the brain is still maturing and, says Taravosh-Lahn, "could possibly react to drugs given to adults in different and potentially negative ways. We need to understand how these drugs will affect the developing nervous system before giving them to children."

The neuroscientists explain that because adolescents may have lower levels of serotonin than adults, there may not be enough of it in their systems for the SSRI to work effectively. In addition, the researchers are investigating whether changing ratios of different subtypes of serotonin receptors ?some of which inhibit and some of which enhance aggression -- are implicated in the findings of higher aggression on low doses.
'"/>

Source:American Psychological Association


Related biology news :

1. Recent breakthroughs in common adult leukemia highlighted in New England Journal of Medicine
2. Study finds adult stem cells can replicate
3. Researchers discover mechanism for multiplying adult stem cells
4. Suppressing growth hormone in early adulthood may prevent cancer
5. A new window into structural plasticity in the adult visual cortex
6. MIT researcher finds neuron growth in adult brain
7. New neurons take baby steps in the adult brain
8. Neurons generated in the adult brain learn to respond to novel stimuli
9. Changes to embryos can elicit change in adult fish
10. Feds give researchers ok for safety test of adult stem cells in patients with heart disease
11. HIV-infected adults in Botswana respond positively to ARV therapy public treatment program

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/31/2016)... PROVIDENCE, R.I. , March 31, 2016  Genomics ... leadership of founding CEO, Barrett Bready , M.D., ... addition, members of the original technical leadership team, including ... Vice President of Product Development, Steve Nurnberg and Vice ... have returned to the company. Dr. Bready ...
(Date:3/23/2016)... , March 23, 2016 ... erhöhter Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender ... das Unternehmen mit SpeechPro zusammenarbeitet, um erstmals ... Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im Rahmen ...
(Date:3/22/2016)... PROVO and SANDY, Utah ... (NSO), which operates the highest sample volume laboratory in ... Tute Genomics and UNIConnect, leaders in clinical sequencing informatics ... the launch of a project to establish the informatics ... NSO has been contracted by the ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... -- A person commits a crime, and the detective uses ... criminal down. An outbreak of foodborne illness makes ... uses DNA evidence to track down the bacteria that caused ... not. The FDA has increasingly used a complex, cutting-edge technology ... Put as simply as possible, whole genome sequencing is a ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... NC (PRWEB) , ... June 23, 2016 , ... In ... University Hospital in Denmark detail how a patient who developed lymphedema after being treated ... tissue. The results could change the paradigm for dealing with this debilitating, frequent side ...
(Date:6/23/2016)... , June 23, 2016 On ... session at 4,833.32, down 0.22%; the Dow Jones Industrial Average ... 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ), Aralez ... Inc. (NASDAQ: BIND ). Learn more about these ...
Breaking Biology Technology: